[
  {
    "ts": null,
    "headline": "Eli Lilly Investments In Production Reach $23 Billion With Additional $3 Billion Expansion At US Facility",
    "summary": "On Thursday, Eli Lilly And Co (NYSE:LLY) announced a $3 billion expansion of its Kenosha County, Wisconsin, manufacturing facility to address the rising demand for diabetes, obesity, and pipeline medicines. This investment, the company’s largest U.S. manufacturing commitment outside Indiana, will create 750 advanced manufacturing jobs and further solidify Wisconsin’s position in the pharmaceutical industry. Also Read: Eli Lilly’s Zepbound Vs. Novo Nordisk’s Wegovy – Which Shows Greater Weight Lo",
    "url": "https://finnhub.io/api/news?id=a77a695964864afcce1a3d6527ed3e3c44a69dae15a86f9226149ca51c2c5fd0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733510525,
      "headline": "Eli Lilly Investments In Production Reach $23 Billion With Additional $3 Billion Expansion At US Facility",
      "id": 131824006,
      "image": "https://media.zenfs.com/en/Benzinga/bbd8b612d729ac3549759c5f8051f626",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "On Thursday, Eli Lilly And Co (NYSE:LLY) announced a $3 billion expansion of its Kenosha County, Wisconsin, manufacturing facility to address the rising demand for diabetes, obesity, and pipeline medicines. This investment, the company’s largest U.S. manufacturing commitment outside Indiana, will create 750 advanced manufacturing jobs and further solidify Wisconsin’s position in the pharmaceutical industry. Also Read: Eli Lilly’s Zepbound Vs. Novo Nordisk’s Wegovy – Which Shows Greater Weight Lo",
      "url": "https://finnhub.io/api/news?id=a77a695964864afcce1a3d6527ed3e3c44a69dae15a86f9226149ca51c2c5fd0"
    }
  },
  {
    "ts": null,
    "headline": "New study finds obesity costs US industry $347bn a year",
    "summary": "Research shows an average weight loss of just 5% could save an annual $153bn in medical fees and lost productivity.",
    "url": "https://finnhub.io/api/news?id=4f9f5bb09e339ec4cf525cffa721db352843f8410f9d17a8b76bf49262d422c4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733510304,
      "headline": "New study finds obesity costs US industry $347bn a year",
      "id": 131829805,
      "image": "https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/24/2024/12/cost-of-obesity.jpg",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Research shows an average weight loss of just 5% could save an annual $153bn in medical fees and lost productivity.",
      "url": "https://finnhub.io/api/news?id=4f9f5bb09e339ec4cf525cffa721db352843f8410f9d17a8b76bf49262d422c4"
    }
  },
  {
    "ts": null,
    "headline": "Nature study finds obesity costs US industry $347bn a year",
    "summary": "Research shows an average weight loss of just 5% could save an annual $153bn in medical fees and lost productivity.",
    "url": "https://finnhub.io/api/news?id=596722c48b8aff2bc6e36af88d59ca8af121d1e13dc2011a2bb019f8f113c6a5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733510304,
      "headline": "Nature study finds obesity costs US industry $347bn a year",
      "id": 131824007,
      "image": "https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/24/2024/12/cost-of-obesity.jpg",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Research shows an average weight loss of just 5% could save an annual $153bn in medical fees and lost productivity.",
      "url": "https://finnhub.io/api/news?id=596722c48b8aff2bc6e36af88d59ca8af121d1e13dc2011a2bb019f8f113c6a5"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock rises Friday, still underperforms market",
    "summary": "Eli Lilly & Co. stock rises Friday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=998945d76c1a692d34b63cce1e2bb58f7927b29301fbe5f85b00fa7b0899d382",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733502780,
      "headline": "Eli Lilly & Co. stock rises Friday, still underperforms market",
      "id": 131873836,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock rises Friday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=998945d76c1a692d34b63cce1e2bb58f7927b29301fbe5f85b00fa7b0899d382"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly to invest $3bn in Wisconsin facility expansion",
    "summary": "The construction for the expansion is scheduled to begin in 2025.",
    "url": "https://finnhub.io/api/news?id=c15f8a3cdfe5f25d6fcc4127f59b55b7af4dae9ebeff68811773224e40c2422d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733499272,
      "headline": "Eli Lilly to invest $3bn in Wisconsin facility expansion",
      "id": 131824008,
      "image": "https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/24/2024/12/Pharma-3-Lillyy-Shutterstock_1850430910.jpg",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The construction for the expansion is scheduled to begin in 2025.",
      "url": "https://finnhub.io/api/news?id=c15f8a3cdfe5f25d6fcc4127f59b55b7af4dae9ebeff68811773224e40c2422d"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand",
    "summary": "Per Lilly, this is its single-largest manufacturing investment in the country outside its home state. It plans to start construction on the expansion next year.",
    "url": "https://finnhub.io/api/news?id=f3f4676453f026f2bd6e131bbe4ddd0febf994c2fa1ba27a8067acc475e1694e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733499240,
      "headline": "Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand",
      "id": 131820827,
      "image": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Per Lilly, this is its single-largest manufacturing investment in the country outside its home state. It plans to start construction on the expansion next year.",
      "url": "https://finnhub.io/api/news?id=f3f4676453f026f2bd6e131bbe4ddd0febf994c2fa1ba27a8067acc475e1694e"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Stock Roundup: LLY's Zepbound Success, FDA Updates for MRK, JNJ",
    "summary": "LLY's Zepbound shows better weight loss than NVO's Wegovy in a study. FDA updates for MRK, RHHBY, JNJ and AZN drugs grab headlines.",
    "url": "https://finnhub.io/api/news?id=e70bb9194184808502f56aa5967756fb7c1cc843fe06659f7d3aa0ad6165f094",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733490660,
      "headline": "Pharma Stock Roundup: LLY's Zepbound Success, FDA Updates for MRK, JNJ",
      "id": 131817999,
      "image": "https://media.zenfs.com/en/zacks.com/4658663242c3a61dee3fef55a1bf4887",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "LLY's Zepbound shows better weight loss than NVO's Wegovy in a study. FDA updates for MRK, RHHBY, JNJ and AZN drugs grab headlines.",
      "url": "https://finnhub.io/api/news?id=e70bb9194184808502f56aa5967756fb7c1cc843fe06659f7d3aa0ad6165f094"
    }
  },
  {
    "ts": null,
    "headline": "How to Play LLY Stock as Zepbound Beats NVO's Wegovy in Obesity Study",
    "summary": "The latest Zepbound data bodes well for Lilly and could help establish the drug as the new standard for obesity medications.",
    "url": "https://finnhub.io/api/news?id=03bec7c3bebe8a8b2712b0f8e6fcdf4d387e035cac712cc431b924d5ab0b4216",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733490060,
      "headline": "How to Play LLY Stock as Zepbound Beats NVO's Wegovy in Obesity Study",
      "id": 131824011,
      "image": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The latest Zepbound data bodes well for Lilly and could help establish the drug as the new standard for obesity medications.",
      "url": "https://finnhub.io/api/news?id=03bec7c3bebe8a8b2712b0f8e6fcdf4d387e035cac712cc431b924d5ab0b4216"
    }
  },
  {
    "ts": null,
    "headline": "AIO: Strong Performance For This Hybrid 'AI' Themed Fund",
    "summary": "The Virtus Artificial Intelligence & Technology Opportunities Fund comes with an attractive distribution yield that is paid monthly. Learn more about AIO CEF here.",
    "url": "https://finnhub.io/api/news?id=fc7a72ff822f54c6a86ddfd61856bf41366819621f5aa70249b31ad4d829369f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733488400,
      "headline": "AIO: Strong Performance For This Hybrid 'AI' Themed Fund",
      "id": 131821628,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1795495467/image_1795495467.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "The Virtus Artificial Intelligence & Technology Opportunities Fund comes with an attractive distribution yield that is paid monthly. Learn more about AIO CEF here.",
      "url": "https://finnhub.io/api/news?id=fc7a72ff822f54c6a86ddfd61856bf41366819621f5aa70249b31ad4d829369f"
    }
  },
  {
    "ts": null,
    "headline": "Lilly adds to obesity drug production push with $3B investment",
    "summary": "The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana and will help make more injectable drugs like fast-selling Zepbound.",
    "url": "https://finnhub.io/api/news?id=a8ad089c1d0495eab2c9567c9520e53101ca4c140817022176fefc4cd2c380fc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733485740,
      "headline": "Lilly adds to obesity drug production push with $3B investment",
      "id": 131824012,
      "image": "https://imgproxy.divecdn.com/XpGY4jJ-UhBd7rm3HhwdAlVXa4GmJSVipcn88ZseUP0/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDkyNDczMjEzX2VHaVhSdTEuanBn.webp",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana and will help make more injectable drugs like fast-selling Zepbound.",
      "url": "https://finnhub.io/api/news?id=a8ad089c1d0495eab2c9567c9520e53101ca4c140817022176fefc4cd2c380fc"
    }
  },
  {
    "ts": null,
    "headline": "Columbia Select Large Cap Growth Fund Q3 2024 Commentary",
    "summary": "Columbia Select Large Cap Growth Fund Institutional Class shares returned -0.22% for Q3 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=f3467f14b00e5766d13b12cd2ef84acbd85e9d51067022a1bbbcee0c0a186a64",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733483100,
      "headline": "Columbia Select Large Cap Growth Fund Q3 2024 Commentary",
      "id": 131819379,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/174691675/image_174691675.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Columbia Select Large Cap Growth Fund Institutional Class shares returned -0.22% for Q3 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=f3467f14b00e5766d13b12cd2ef84acbd85e9d51067022a1bbbcee0c0a186a64"
    }
  },
  {
    "ts": null,
    "headline": "Columbia Select Large Cap Equity Fund Q3 2024 Commentary",
    "summary": "Columbia Select Large Cap Equity Fund Institutional Class shares returned 3.08% for Q3 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=9622a17c68ca5a6269dcbcdc9c0819807e31902692f7106bc2bd9549f948e723",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733482200,
      "headline": "Columbia Select Large Cap Equity Fund Q3 2024 Commentary",
      "id": 131818971,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359707556/image_1359707556.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Columbia Select Large Cap Equity Fund Institutional Class shares returned 3.08% for Q3 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=9622a17c68ca5a6269dcbcdc9c0819807e31902692f7106bc2bd9549f948e723"
    }
  },
  {
    "ts": null,
    "headline": "Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street",
    "summary": "The billionaire recently bought an obesity drug stock that could soar nearly 20% over the next 12 months, according to Wall Street.  Englander loaded up on Eli Lilly (NYSE: LLY) stock in Q3.  Lilly ranked as the seventh-largest-holding in Millennium Management's portfolio at the end of Q3 with a valuation of over $877 million.",
    "url": "https://finnhub.io/api/news?id=582156eb0ce38b9ce5e7dd0fa8fb75a9b510e53364df3616f652777e90a7f7f7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733482020,
      "headline": "Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street",
      "id": 131824013,
      "image": "https://g.foolcdn.com/editorial/images/799927/scales-with-tape-measure.jpg",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The billionaire recently bought an obesity drug stock that could soar nearly 20% over the next 12 months, according to Wall Street.  Englander loaded up on Eli Lilly (NYSE: LLY) stock in Q3.  Lilly ranked as the seventh-largest-holding in Millennium Management's portfolio at the end of Q3 with a valuation of over $877 million.",
      "url": "https://finnhub.io/api/news?id=582156eb0ce38b9ce5e7dd0fa8fb75a9b510e53364df3616f652777e90a7f7f7"
    }
  },
  {
    "ts": null,
    "headline": "Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup",
    "summary": "Some patients taking weight-loss drugs, including popular GLP-1 treatments like Ozempic (NVO) and Wegovy, reported reducing their consumption of alcohol, according to a new study published recently in the scientific journal JAMA Network Open. Eli Lilly released results this week of a clinical trial comparing its weigh-loss drug Zepbound (LLY) against its rival Novo Nordisk’s Wegovy. Function Health, a lab tests startup, announced this week that its members will now have access to a first-of-its-",
    "url": "https://finnhub.io/api/news?id=7c323d5e438dcf4d5ac772091a41d152490e98280982b37a8c1b0a0cac99fe73",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733479200,
      "headline": "Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup",
      "id": 131820853,
      "image": "https://media.zenfs.com/en/quartz.com/b599e532ad5083fcfbc2bc2a20f9b2a9",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Some patients taking weight-loss drugs, including popular GLP-1 treatments like Ozempic (NVO) and Wegovy, reported reducing their consumption of alcohol, according to a new study published recently in the scientific journal JAMA Network Open. Eli Lilly released results this week of a clinical trial comparing its weigh-loss drug Zepbound (LLY) against its rival Novo Nordisk’s Wegovy. Function Health, a lab tests startup, announced this week that its members will now have access to a first-of-its-",
      "url": "https://finnhub.io/api/news?id=7c323d5e438dcf4d5ac772091a41d152490e98280982b37a8c1b0a0cac99fe73"
    }
  },
  {
    "ts": null,
    "headline": "Columbia Large Cap Growth Fund Q3 2024 Commentary",
    "summary": "Columbia Large Cap Growth Fundâs Institutional Class shares returned 2.20% for the \nthree months ending September 30, 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=6acf19ee9266fa41316d3fe50ca99882960b528bf978f0d4a34095dedd548225",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733474400,
      "headline": "Columbia Large Cap Growth Fund Q3 2024 Commentary",
      "id": 131816273,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1455061998/image_1455061998.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Columbia Large Cap Growth Fundâs Institutional Class shares returned 2.20% for the \nthree months ending September 30, 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=6acf19ee9266fa41316d3fe50ca99882960b528bf978f0d4a34095dedd548225"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Have Defied a Turbulent Week. Fed, Trump Can Spark Further Market Volatility and 5 Other Things to Know Today.",
    "summary": "Stocks Have Defied a Turbulent Week. Fed, Trump Can Spark Further Market Volatility and 5 Other Things to Know Today.",
    "url": "https://finnhub.io/api/news?id=7ad70ead77cb27238edada4227fab691fdc8169d5e0b03c06fb43b4d6ecff595",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733469720,
      "headline": "Stocks Have Defied a Turbulent Week. Fed, Trump Can Spark Further Market Volatility and 5 Other Things to Know Today.",
      "id": 131873622,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Stocks Have Defied a Turbulent Week. Fed, Trump Can Spark Further Market Volatility and 5 Other Things to Know Today.",
      "url": "https://finnhub.io/api/news?id=7ad70ead77cb27238edada4227fab691fdc8169d5e0b03c06fb43b4d6ecff595"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: massive investment in Wisconsin site",
    "summary": "On Thursday evening, Eli Lilly announced a $3 billion investment to expand its Kenosha County, Wisconsin plant, acquired earlier this year. The expansion is scheduled to begin next year. This will...",
    "url": "https://finnhub.io/api/news?id=29660e20c09b1d28b9a986521bd53a9a194cf7c3b55e2bc7e9f784cdd8b8b4b5",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733459535,
      "headline": "Eli Lilly: massive investment in Wisconsin site",
      "id": 131812663,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "On Thursday evening, Eli Lilly announced a $3 billion investment to expand its Kenosha County, Wisconsin plant, acquired earlier this year. The expansion is scheduled to begin next year. This will...",
      "url": "https://finnhub.io/api/news?id=29660e20c09b1d28b9a986521bd53a9a194cf7c3b55e2bc7e9f784cdd8b8b4b5"
    }
  }
]